Concentric Analgesics, Inc. Alternatives & Competitors

12 companies similar to Concentric Analgesics, Inc. — Our mission is to dramatically improve the lives of patients by developing break...

Akelos Inc

Developing Opioid Alternatives for Treating Neuropathic Pain. Now Recruiting Accredited In...

5 Grant $2.05M

New York, United States

Biopharma Biotechnology +2

Centrexion Therapeutics Corp.

We aim to relieve the suffering associated with chronic pain by creating treatments that a...

23 Venture round $229.16M

Boston, United States

Biotechnology Health Care +1

Recro Pharma

Pioneering non-opioid pain therapeutics for post-surgical care.

Post-IPO Equity $274.80M

Biotechnology Health Care +1

Latigo Biotherapeutics, Inc.

Uniquely poised to disrupt pain therapy.

57 Series B $285.00M

Thousand Oaks, United Sta...

Biotechnology Health Care +2

Rival Readout

Competing with Concentric Analgesics, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Hoba Therapeutics

Developing Restorative Treatments for Chronic Neuropathic Pain and Hearing Loss

15 Series A $27.40M

Denmark

Biotechnology Health Care +1

BioWave Corporation

BioWave is a non-opioid, FDA cleared, professional athlete-proven, and trusted pain relie...

70 Venture round $3.10M

Norwalk, United States

Biotechnology Health Care +3

Aegera Therapeutics Inc.

6 Debt Financing $38.00M

Biotechnology Health Care +1

THRASOS LIMITED

Pioneering targeted therapies to prevent and treat severe organ failure, with a focus on k...

2 Series D $56.00M

Biotechnology Health Care +2

Proniras Corporation

Clinical-stage biotechnology developing therapeutics for the treatment of substance use &...

4 Series B $13.25M

Seattle, United States

Biotechnology Health Care +2

Elysium Therapeutics, Inc.

Reducing suffering from severe pain, opioid abuse and fatal overdose

6 Private Equity $1.58M

Akron, United States

Biotechnology Health Care +2

Tafalgie Therapeutics

Recherche & innovation du traitement des douleurs

15 Series A $12.00M

Marseille, France

Biopharma Biotechnology +1

Angitia Biopharmaceuticals

Developing innovative medicines to address serious musculoskeletal diseases

52 Series B $156.00M

Westlake Village, United...

Biopharma Biotechnology +1

About Concentric Analgesics, Inc.

Concentric Analgesics, Inc. is a private, biotechnology company founded in 2014 with a mission to develop breakthrough non-opioid pain therapeutics aimed at improving the lives of patients. Operating within the Biotechnology and Health Care industries, the company is focused on discovering and developing novel, non-opi...

Business keywords

Pain Management, Non-opioid Therapeutics, Drug Development, Acute Pain, Chronic Pain, Medical Innovation

Frequently Asked Questions

Companies similar to Concentric Analgesics, Inc. include Akelos Inc, Centrexion Therapeutics Corp., Recro Pharma, Latigo Biotherapeutics, Inc., Hoba Therapeutics. They work in Biotechnology and Health Care and share Concentric Analgesics, Inc.'s focus on drug development, chronic pain and pain management.

Bounce Watch lists 12 companies that share Concentric Analgesics, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Concentric Analgesics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Concentric Analgesics, Inc. Profile Akelos Inc Alternatives Centrexion Therapeutics Corp. Alternatives Recro Pharma Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Concentric Analgesics, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.